Paraneoplastic neuromyelitis optica spectrum disorders: Three new cases and a review of the literature

International Journal of Neuroscience

Volumn 126, Issue 7, 2016, Pages 660-668

  Cai, Gang ^a   He, Dian ^a   Chu, Lan ^a   Dai, Qingqing ^a   Xu, Zhu ^a   Zhang, Yifan ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

AQP4 IgG; longitudinally extensive transverse myelitis; neuromyelitis optica spectrum disorders; NMO IgG; optic neuritis; paraneoplastic syndrome

Indexed keywords

AQUAPORIN 4 ANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN G; LIOTHYRONINE; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB;

ADOLESCENT; ADULT; AFFERENT PUPILLARY DEFECT; AXILLARY LYMPH NODE; BLURRED VISION; BONE MARROW BIOPSY; BREAST BIOPSY; BREAST CARCINOMA; CANCER THERAPY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CERVICAL SPINAL CORD; CORTICOSTEROID THERAPY; DYSARTHRIA; DYSPHAGIA; ECHOGRAPHY; EVOKED VISUAL RESPONSE; EYE EXAMINATION; FEMALE; HICCUP; HUMAN; LEUKOCYTE COUNT; LIMB WEAKNESS; LIOTHYRONINE BLOOD LEVEL; LOBECTOMY; LYMPH NODE DISSECTION; MAINTENANCE THERAPY; MALE; MAMMOGRAPHY; MASTECTOMY; MEDULLA OBLONGATA; MONOCLONAL IMMUNOGLOBULINEMIA; MUSCLE CRAMP; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROMYELITIS OPTICA SPECTRUM DISORDER; PARANEOPLASTIC SYNDROME; PLASMAPHERESIS; REVIEW; SEX RATIO; SPINAL CORD DISEASE; SYSTEMATIC REVIEW; THYROID CARCINOMA; THYROID FUNCTION; TUMOR DIAGNOSIS; VISUAL ACUITY; VOMITING; DIAGNOSTIC IMAGING; NEUROMYELITIS OPTICA; ONSET AGE; PARANEOPLASTIC SYNDROMES, OCULAR; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGE OF ONSET; FEMALE; HUMANS; MALE; NEUROMYELITIS OPTICA; PARANEOPLASTIC SYNDROMES, OCULAR;

EID: 84939546346     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2015.1054481     Document Type: Review

References (32)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-15
2. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-12
3. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-9
4. Pittock SJ, Lennon VA. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol 2008; 65: 629-32
5. Mueller S, Dubal DB, Josephson SA. A case of paraneoplastic myelopathy associated with the neuromyelitis optica antibody. Nat Clin Pract Neurol 2008; 4: 284-8
6. Armaǧan H, Tüzün E, Içöz S, et al. Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: favorable response to cancer treatment. J Spinal Cord Med 2012; 35: 267-9
7. Ontaneda D, Fox RJ. Is neuromyelitis optica with advanced age of onset a paraneoplastic disorder? Int J Neurosci 2014; 124: 509-11
8. De Santis G, Caniatti L, De Vito A, et al. A possible paraneoplastic neuromyelitis optica associated with lung cancer. Neurol Sci 2009; 30: 397-400
9. Iorio R, Rindi G, Erra C, et al. Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4. Mult Scler 2015; 21 (6): 791-4
10. Yang HK, Woo SJ, Park WY, Hwang JM. Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma. BMC Ophthalmol 2014; 14: 106
11. Kitazawa Y, Warabi Y, Bandoh M, et al. Elderly-onset neuromyelitis optica which developed after the diagnosis of prostate adenocarcinoma and relapsed after a 23-valent pneumococcal polysaccharide vaccination. Intern Med 2012; 51: 103-7
12. Nakayama-Ichiyama S, Yokote T, Hiraoka N, et al. A paraneoplastic neuromyelitis optica spectrum disorder associated with a mature B-cell neoplasm. Leuk Res 2011; 35: e111-3
13. Figueroa M, Guo Y, Tselis A, et al. Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. JAMA Neurol 2014; 71: 495-8
14. Al-Harbi T, Al-Sarawi A, Binfalah M, Dermime S. Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor. Hematol Oncol Stem Cell Ther 2014; 7: 116-9
15. Frasquet M, Bataller L, Torres-Vega E, et al. Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma. J Neuroimmunol 2013; 263: 145-7
16. Zoccarato M, Saddi MV, Serra G, et al. Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis. J Neurol 2013; 260: 3185-7
17. Collongues N, Marignier R, Zéphir H, et al. Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology 2010; 74: 736-42
18. Stich O, Murek C, Rasiah C, Rauer S. Screening for well-characterized paraneoplastic antineuronal antibodies in multiple sclerosis. Int J Neurosci 2011; 121: 477-9
19. Marrie R, Horwitz R, Cutter G, et al. Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler 2008; 14: 1091-8
20. Apiwattanakul M, Popescu BF, Matiello M, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol 2010; 68: 757-61
21. Verkman AS. Aquaporins in clinical medicine. Annu Rev Med 2012; 63: 303-16
22. The Human Protein Atlas. Cancer Atlas. Available from: http://www.proteinatlas.org/[. accessed 20 December 2014 ]
23. Chan KH, Kwan JS, Ho PW, et al. Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis. J Neuroimmunol 2010; 227: 178-84
24. Iorio R, Lucchinetti CF, Lennon VA, et al. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology 2011; 77: 1644-46
25. Hofman P, Hoyng P, vanderWerf F, et al. Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. Invest Ophthalmol Vis Sci 2001; 42: 895-901
26. Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M. The blood-spinal cord barrier: morphology and clinical implications. Ann Neurol 2011; 70: 194-206
27. Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012; 11: 535-44
28. Itou J, Tanaka S, Sato F, et al. An optical labeling-based proliferation assay system reveals the paracrine effect of interleukin-6 in breast cancer. Biochim Biophys Acta 2015; 1853: 27-40
29. Jarius S, Wandinger KP, Borowski K, et al. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg. 2012; 114: 331-5
30. Ducray F, Roos-Weil R, Garcia PY, et al. Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 2007; 78: 325-7
31. Pittock SJ, Lucchinetti CF, Parisi JE, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 2005; 58: 96-107
32. Vernino S, Eggenberger ER, Rogers LR, Lennon VA. Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma. Neurology 2002; 59: 929-32